Analytical insights reveal key biosynthetic genes for galantamine in Lycoris, suggesting avenues for enhanced production.
Galantamine, a clinically essential Amaryllidaceae alkaloid widely used to treat Alzheimer’s disease, faces a constrained and unsustainable plant-derived supply, yet our understanding of its biosynthesis in Lycoris is relatively limited. Here, we provide the first comprehensive elucidation of galantamine biosynthesis in Lycoris longituba , a species with exceptionally high galantamine content. Comparative alkaloid metabolomics between L. longituba and the low-galantamine species L. insularis revealed ∼10-fold higher galantamine accumulation in L. longituba , particularly at the S1 developmental stage (November), when all precursor metabolites were markedly enriched. Using PacBio full-length and Illumina short-read transcriptomes, we identified 83 differentially expressed isoquinoline alkaloid genes, 53 of which were upregulated in L. longituba . Furthermore, integrative correlation of DEGs-metabolite networks analysis combined with Nicotiana benthamiana transient assays functionally identified Ll NMT1, an N-methyltransferase, co-expressed with NtCYP96T6, converting 4’-O-methylnorbelladine to narwedine, and Ll AKR4, an aldo-keto reductase mediating narwedine conversion to galantamine. In addition, we cloned cytochrome P450 candidates for the oxidative coupling of 4’-O-methylnorbelladine, obtaining 21 and 18 CYP96T-like sequences from L. longituba and L. insularis , respectively. Phylogenetic screening yielded 10 candidates, of which only LlCYP96T_clone20 and LiCYP96T_clone1 produced a galantamine-matching peak in 35S::LlAKR4-p2A-LlNMT1 tobacco, with LlCYP96T_clone20 showing ∼2.89-fold higher response. Moreover, structural modelling of the ten CYP96T-like proteins further suggested that a conserved residue, Ile386 adjacent to the heme cofactor, plays an important role in catalytic efficiency. Collectively, our work not only elucidates the downstream biosynthetic pathway from 4’-O-methylnorbelladine to galantamine in Lycoris , but also lays a robust molecular foundation for heterologous production in engineered plant chassis and the subsequent development of its clinical and industrial applications. • Integrative multi-omics identifies key pathway genes and developmental stage (S1) for high galantamine accumulation in Lycoris longituba. • Ll NMT1 and Ll AKR4 contribute to downstream conversions in galantamine biosynthesis. • A specific cytochrome P450 ( Ll CYP96T_clone20) plays an important role in catalytic efficiency, with Ile386 identified as a key residue affecting enzyme function.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: